Omeros Corp (OMER)

May 05, 2026

Omeros (NASDAQ:OMER) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

May 05, 2026

May 01, 2026

OMEROS CORP ($OMER) CEO 2025 Pay Revealed - Quiver Quantitative

May 01, 2026

May 01, 2026

OMER Forecast, Price Target & Analyst Ratings | OMEROS CORP (NASDAQ:OMER) - ChartMill

May 01, 2026

Apr 30, 2026

Executive pay, incentives and votes detailed in Omeros (NASDAQ: OMER) 2026 proxy - Stock Titan

Apr 30, 2026

Apr 30, 2026

[ARS] OMEROS CORP SEC Filing - Stock Titan

Apr 30, 2026

Apr 30, 2026

OMER stock on track for best week in nearly 4 months after receiving permanent reimbursement code for treatment - MSN

Apr 30, 2026

Apr 28, 2026

Omeros rises as Novo deal boosts Q4 earnings - MSN

Apr 28, 2026

Apr 28, 2026

OMER stock surges 5% after hours on Novo Nordisk deal windfall and drug launch optimism - MSN

Apr 28, 2026

Apr 28, 2026

Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway - Yahoo Finance

Apr 28, 2026

Apr 27, 2026

Omeros Stock Logs Best Session Ever After HC Wainwright Doubles Target On Novo Nordisk Deal; Retail Sees Big Upside - MSN

Apr 27, 2026

Apr 27, 2026

Omeros (NASDAQ:OMER) Trading 6.3% HigherShould You Buy? - MarketBeat

Apr 27, 2026

Apr 27, 2026

Here's Why Omeros (OMER) is a Great Momentum Stock to Buy - Yahoo Finance

Apr 27, 2026

Apr 27, 2026

Wall Street Analysts Believe Omeros (OMER) Could Rally 222.76%: Here's is How to Trade - Yahoo Finance

Apr 27, 2026

Apr 26, 2026

Omeros (NASDAQ:OMER) Lowered to Hold Rating by Wall Street Zen - MarketBeat

Apr 26, 2026

Apr 25, 2026

how Fair Value analysis identified Omeros’ 74% biotech breakout By Investing.com - Investing.com South Africa

Apr 25, 2026

Apr 25, 2026

how Fair Value analysis identified Omeros’ 74% biotech breakout - Investing.com

Apr 25, 2026

Apr 24, 2026

Omeros Q4 2025 earnings preview - MSN

Apr 24, 2026

Apr 24, 2026

OMER Stock Price, Quote & Chart | OMEROS CORP (NASDAQ:OMER) - ChartMill

Apr 24, 2026

Apr 23, 2026

Omeros Corporation to acquire $80.5 million of its convertible senior notes due 2026 - MSN

Apr 23, 2026

Apr 23, 2026

Ingalls & Snyder (NASDAQ: OMER) holds 3.47M shares, 4.8% stake - Stock Titan

Apr 23, 2026

Apr 23, 2026

OMER (Omeros Corporation) shares rise 7.18 percent after Q4 2025 earnings sharply outperform analyst estimates.Hot Momentum Watchlist - Xã Thanh Hà

Apr 23, 2026

Apr 21, 2026

OMER Maintained by D. Boral Capital -- Price Target Remains at $36 - GuruFocus

Apr 21, 2026

Apr 21, 2026

Omeros Is Maintained at Buy by D. Boral Capital - Moomoo

Apr 21, 2026

Apr 21, 2026

D. Boral Capital Reiterates "Buy" Rating for Omeros (NASDAQ:OMER) - MarketBeat

Apr 21, 2026

Apr 21, 2026

Sagimet Biosciences (SGMT) CMO retires as company appoints successor - Stock Titan

Apr 21, 2026

Apr 20, 2026

Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer - GlobeNewswire Inc.

Apr 20, 2026

Apr 19, 2026

OMER Stock On Track For Best Week In Nearly 4 Months After Receiving Permanent Reimbursement Code For Treatment - Stocktwits

Apr 19, 2026

Apr 18, 2026

Omeros (NASDAQ:OMER) Rating Increased to Buy at Wall Street Zen - MarketBeat

Apr 18, 2026

Apr 17, 2026

Omeros CorporationCMS Assigns Permanent Reimbursement J-Code for YARTEMLEA - marketscreener.com

Apr 17, 2026

Apr 17, 2026

Omeros receives permanent J-code for TA-TMA treatment Yartemlea By Investing.com - Investing.com India

Apr 17, 2026

Apr 17, 2026

CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug) - BioSpace

Apr 17, 2026

Apr 16, 2026

Omeros (OMER) Secures Permanent J-Code for YARTEMLEA - GuruFocus

Apr 16, 2026

Apr 16, 2026

Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA - TipRanks

Apr 16, 2026